Literature DB >> 18414205

Genetic aspects of Alzheimer disease.

Thomas D Bird1.   

Abstract

Alzheimer disease is the most common cause of dementia and represents a major public health problem. The neuropathologic findings of amyloid-beta plaques and tau containing neurofibrillary tangles represent important molecular clues to the underlying pathogenesis. Genetic factors are well recognized, but complicated. Three rare forms of autosomal-dominant early-onset familial Alzheimer disease have been identified and are associated with mutations in amyloid precursor protein, presenilin 1, and presenilin 2 genes. The more common late-onset form of Alzheimer disease is assumed to be polygenic/multifactorial. However, thus far the only clearly identified genetic risk factor for Alzheimer disease is Apo lipoprotein E. The epsilon4 allele of Apo lipoprotein E influences age at onset of Alzheimer disease, but is neither necessary nor sufficient for the disease. The search continues for the discovery of additional genetic influences.

Entities:  

Mesh:

Year:  2008        PMID: 18414205      PMCID: PMC2690397          DOI: 10.1097/GIM.0b013e31816b64dc

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  114 in total

1.  Specificity of the fivefold increase in AD in mothers of adults with Down syndrome.

Authors:  N Schupf; D Kapell; B Nightingale; J H Lee; J Mohlenhoff; S Bewley; R Ottman; R Mayeux
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

Review 2.  Molecular genetics of late-onset Alzheimer's disease.

Authors:  M Ilyas Kamboh
Journal:  Ann Hum Genet       Date:  2004-07       Impact factor: 1.670

3.  Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Authors:  G Li; E B Larson; J A Sonnen; J B Shofer; E C Petrie; A Schantz; E R Peskind; M A Raskind; J C S Breitner; T J Montine
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

4.  Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

Authors:  A M Saunders; O Hulette; K A Welsh-Bohmer; D E Schmechel; B Crain; J R Burke; M J Alberts; W J Strittmatter; J C Breitner; C Rosenberg
Journal:  Lancet       Date:  1996-07-13       Impact factor: 79.321

5.  Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.

Authors:  G Raux; L Guyant-Maréchal; C Martin; J Bou; C Penet; A Brice; D Hannequin; T Frebourg; D Campion
Journal:  J Med Genet       Date:  2005-07-20       Impact factor: 6.318

Review 6.  Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.

Authors: 
Journal:  JAMA       Date:  1995 Nov 22-29       Impact factor: 56.272

7.  Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions.

Authors:  L L Heston; A R Mastri; V E Anderson; J White
Journal:  Arch Gen Psychiatry       Date:  1981-10

8.  Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

Authors:  S Gilman; M Koller; R S Black; L Jenkins; S G Griffith; N C Fox; L Eisner; L Kirby; M Boada Rovira; F Forette; J-M Orgogozo
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

9.  A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.

Authors:  Andrew Grupe; Yonghong Li; Charles Rowland; Petra Nowotny; Anthony L Hinrichs; Scott Smemo; John S K Kauwe; Taylor J Maxwell; Sara Cherny; Lisa Doil; Kristina Tacey; Ryan van Luchene; Amanda Myers; Fabienne Wavrant-De Vrièze; Mona Kaleem; Paul Hollingworth; Luke Jehu; Catherine Foy; Nicola Archer; Gillian Hamilton; Peter Holmans; Chris M Morris; Joseph Catanese; John Sninsky; Thomas J White; John Powell; John Hardy; Michael O'Donovan; Simon Lovestone; Lesley Jones; John C Morris; Leon Thal; Michael Owen; Julie Williams; Alison Goate
Journal:  Am J Hum Genet       Date:  2005-11-15       Impact factor: 11.025

10.  The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort.

Authors:  Alison K Godbolt; Lisa Cipolotti; Hilary Watt; Nick C Fox; John C Janssen; Martin N Rossor
Journal:  Arch Neurol       Date:  2004-11
View more
  90 in total

1.  Family-based association analysis of NAV2 gene with the risk and age at onset of Alzheimer's disease.

Authors:  Ke-Sheng Wang; Ying Liu; Chun Xu; Xuefeng Liu; Xingguang Luo
Journal:  J Neuroimmunol       Date:  2017-06-27       Impact factor: 3.478

2.  Neurogenesis in Alzheimer´s disease: a realistic alternative to neuronal degeneration?

Authors:  Rocío E Gonzalez-Castaneda; Alma Y Galvez-Contreras; Sonia Luquín; Oscar Gonzalez-Perez
Journal:  Curr Signal Transduct Ther       Date:  2011-09-01

3.  Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.

Authors:  Brian W Kunkle; James Jaworski; Sandra Barral; Badri Vardarajan; Gary W Beecham; Eden R Martin; Laura S Cantwell; Amanda Partch; Thomas D Bird; Wendy H Raskind; Anita L DeStefano; Regina M Carney; Michael Cuccaro; Jeffrey M Vance; Lindsay A Farrer; Alison M Goate; Tatiana Foroud; Richard P Mayeux; Gerard D Schellenberg; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Alzheimers Dement       Date:  2015-09-11       Impact factor: 21.566

4.  Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease.

Authors:  Vincenzo De Luca; Maria Donata Orfei; Sara Gaudenzi; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-12-29       Impact factor: 5.270

5.  NLRP1 and NTN1, Deregulated Blood Differentially Methylated Regions in Mild Cognitive Impairment Patients.

Authors:  Min-Koo Park; Ji-Won Lee; Jeong-Chan Lee; Sung-Joo Hwang; Hyun Woong Roh; Chang Hyung Hong; Sang Joon Son
Journal:  J Mol Neurosci       Date:  2018-11-05       Impact factor: 3.444

6.  Accuracy of reported family history and effectiveness of medical record requests in genetic counseling for Alzheimer disease.

Authors:  Emily L R Alexander; Rachel K Butler; Colleen Guimond; Blair Butler; A Dessa Sadovnick
Journal:  J Genet Couns       Date:  2010-09-28       Impact factor: 2.537

7.  Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

Authors:  Michael B Dinkins; Somsankar Dasgupta; Guanghu Wang; Gu Zhu; Erhard Bieberich
Journal:  Neurobiol Aging       Date:  2014-02-15       Impact factor: 4.673

8.  Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.

Authors:  Brian J Lopresti; Elizabeth M Campbell; Zheming Yu; Stewart J Anderson; Ann D Cohen; Davneet S Minhas; Beth E Snitz; Sarah K Royse; Carl R Becker; Howard J Aizenstein; Chester A Mathis; Oscar L Lopez; William E Klunk; Dana L Tudorascu
Journal:  Neurobiol Aging       Date:  2020-05-31       Impact factor: 4.673

9.  Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum.

Authors:  R Migliaccio; F Agosta; K Rascovsky; A Karydas; S Bonasera; G D Rabinovici; B L Miller; M L Gorno-Tempini
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

10.  Genetics of Alzheimer disease.

Authors:  A T Rao; A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-28       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.